Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15 , 220–231 (2009). Article Google Scholar ...

北京时间9月13日，备受瞩目的2024年欧洲肿瘤内科学会（ESMO）大会在西班牙巴塞罗那盛大开幕。作为全球肿瘤学领域最具影响力的盛会之一，本次大会吸引了众多世界顶级专家汇聚一堂，共同探讨和分享肿瘤学领域的最新科研成果与治疗技术。

South San Francisco, CA) is a prototypic antiangiogenic compound, and has proven therapeutic benefit combined with conventional chemotherapy—namely, significantly improved progression-free ...

作为创新型国际化制药企业，恒瑞医药长期坚持“科技为本，为人类创造健康生活”的使命，针对肿瘤等严重威胁人类生命健康的疾病开展科研攻关，已上市的17款1类创新药中抗肿瘤创新药达9款。公司另有90多个自主创新产品正在临床开发，300余项临床试验在国内外开展。本次ESMO大会，公司携13款创新药的37项抗肿瘤领域研究登上国际学术舞台，奏响了抗肿瘤领域自主创新实力的强音，也是中国医药研发创新力量的展现。

The combination of ramucirumab with trifluridine/tipiracil failed to show improvements in overall survival vs TAS-102 alone ...

邱海波 中山大学肿瘤防治中心 The Final Results of Pulmonary Resectable Metastases of Osteosarcoma With Antiangiogenic and CHemotherapy（PROACH）：An open-label, single-arm phase 2 clinical trial ...

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the ...

Treatment with Cyramza plus Lonsurf did not improve overall survival compared with Lonsurf alone in heavily pretreated ...

Deeper knowledge of the biology of ovarian cancer has led to the identification of multiple molecular targets, such as growth factor receptors, signal transduction pathways, cell cycle regulators ...

India can be a top turmeric supplier for global nutraceuticals. Standardised farming and post-harvest practices are a must ...

In that case, there wouldn't really be any reason to change from where we are today, saving antiangiogenic agents for part of later-line therapy after progression on pembrolizumab-based treatment.